These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30273933)

  • 21. Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy.
    Sella EM; Sato EI; Barbieri A
    Arthritis Rheum; 2003 Nov; 48(11):3168-75. PubMed ID: 14613279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance.
    Mavrogeni S; Bratis K; Sfendouraki E; Papadopoulou E; Kolovou G
    Inflamm Allergy Drug Targets; 2013 Jun; 12(3):206-11. PubMed ID: 23547732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus.
    Myhr KA; Zinglersen AH; Pecini R; Jacobsen S
    Int J Cardiovasc Imaging; 2024 Jan; 40(1):127-137. PubMed ID: 37814154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients.
    Varma N; Hinojar R; D'Cruz D; Arroyo Ucar E; Indermuehle A; Peel S; Greil G; Gaddum N; Chowienczyk P; Nagel E; Botnar RM; Puntmann VO
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):762-70. PubMed ID: 25051945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.
    Sella EM; Sato EI; Leite WA; Oliveira Filho JA; Barbieri A
    Ann Rheum Dis; 2003 Nov; 62(11):1066-70. PubMed ID: 14583569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.
    Vincenti G; Masci PG; Monney P; Rutz T; Hugelshofer S; Gaxherri M; Muller O; Iglesias JF; Eeckhout E; Lorenzoni V; Pellaton C; Sierro C; Schwitter J
    JACC Cardiovasc Imaging; 2017 May; 10(5):526-537. PubMed ID: 28412420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left and right ventricular morphology, function and late gadolinium enhancement extent and localization change with different clinical presentation of acute myocarditis Data from the ITAlian multicenter study on MYocarditis (ITAMY).
    Di Bella G; Camastra G; Monti L; Dellegrottaglie S; Piaggi P; Moro C; Pepe A; Lanzillo C; Pontone G; Perazzolo Marra M; Di Roma M; Scatteia A; Aquaro GD;
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):881-887. PubMed ID: 28915139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis.
    Mavrogeni SI; Bratis K; Karabela G; Spiliotis G; Wijk Kv; Hautemann D; Reiber JH; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Kolovou G; Stavropoulos E
    Inflamm Allergy Drug Targets; 2015; 14(1):29-36. PubMed ID: 26374223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases.
    Mavrogeni S; Sfikakis PP; Gialafos E; Bratis K; Karabela G; Stavropoulos E; Spiliotis G; Sfendouraki E; Panopoulos S; Bournia V; Kolovou G; Kitas GD
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):104-12. PubMed ID: 24106233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
    Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
    Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report.
    Singh JA; Woodard PK; Dávila-Román VG; Waggoner AD; Gutierrez FR; Zheng J; Eisen SA
    Lupus; 2005; 14(2):137-44. PubMed ID: 15751818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction.
    Di Bella G; Pingitore A; Piaggi P; Pizzino F; Barison A; Terrizzi A; d'angelo M; Todiere G; Quattrocchi S; Carerj S; Emdin M; Aquaro GD
    Int J Cardiol; 2016 Dec; 224():337-342. PubMed ID: 27668708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive value of magnetic resonance coronary angiography in a comprehensive cardiac magnetic resonance stress-rest protocol for detection of functionally significant coronary artery disease: a pilot study.
    Bettencourt N; Ferreira N; Chiribiri A; Schuster A; Sampaio F; Santos L; Melica B; Rodrigues A; Braga P; Teixeira M; Leite-Moreira A; Silva-Cardoso J; Portugal P; Gama V; Nagel E
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):730-8. PubMed ID: 23833284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Detection of Silent Myocardial Impairment in Drug-Naive Patients With New-Onset Systemic Lupus Erythematosus: A Three-Center Prospective Study.
    Guo Q; Wu LM; Wang Z; Shen JY; Su X; Wang CQ; Gong XR; Yan QR; He Q; Zhang W; Xu JR; Jiang M; Pu J
    Arthritis Rheumatol; 2018 Dec; 70(12):2014-2024. PubMed ID: 30070061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus.
    Mavrogeni S; Koutsogeorgopoulou L; Dimitroulas T; Markousis-Mavrogenis G; Boki K; Katsifis G; Vartela V; Kallenberg CG; Kolovou G; Kitas G
    Curr Cardiol Rev; 2020; 16(3):178-186. PubMed ID: 31368877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
    Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
    Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular magnetic resonance imaging in myocardial involvement of systemic lupus erythematosus.
    Luo S; Dou WQ; Schoepf UJ; Varga-Szemes A; Pridgen WT; Zhang LJ
    Trends Cardiovasc Med; 2023 Aug; 33(6):346-354. PubMed ID: 35150849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial perfusion in women with systemic lupus erythomatosus and no symptoms of coronary artery disease.
    Czuszyńska Z; Romanowicz G
    Nucl Med Rev Cent East Eur; 2004; 7(2):171-4. PubMed ID: 15968605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance.
    Mavrogeni S; Sfikakis PP; Dimitroulas T; Koutsogeorgopoulou L; Karabela G; Katsifis G; Stavropoulos E; Gialafos E; Spiliotis G; Kolovou G; Kitas GD
    Inflamm Allergy Drug Targets; 2015; 14(2):111-6. PubMed ID: 26728774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.